Skip to content

A study investigating the absorption and food effect of different tablet formulations of JNJ-77242113, a new compound in the treatment of inflammatory diseases

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504720-26-00
Enrollment
24
Registered
2023-06-28
Start date
2023-07-19
Completion date
2023-09-11
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Conditions

Interventions

None listed

Sponsors

Janssen - Cilag International
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026